Budd-Chiari syndrome screening: Difference between revisions

Jump to navigation Jump to search
Mazia Fatima (talk | contribs)
No edit summary
Skazmi (talk | contribs)
No edit summary
 
Line 2: Line 2:
{{Budd-Chiari syndrome}}
{{Budd-Chiari syndrome}}
{{CMG}}; {{AE}}{{Mazia}}
{{CMG}}; {{AE}}{{Mazia}}
{{PleaseHelp}}


==Overview==
==Overview==

Latest revision as of 18:02, 30 November 2017

Budd-Chiari syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Budd-Chiari syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Budd-Chiari syndrome screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Budd-Chiari syndrome screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Budd-Chiari syndrome screening

CDC on Budd-Chiari syndrome screening

Budd-Chiari syndrome screening in the news

Blogs on Budd-Chiari syndrome screening

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Budd-Chiari syndrome screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]

Overview

There is insufficient evidence to recommend routine screening for Budd-Chiari syndrome.

Screening

There is insufficient evidence to recommend routine screening for Budd-Chiari syndrome.

References

Template:WS Template:WH